<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00038948</url>
  </required_header>
  <id_info>
    <org_study_id>0468H1-316</org_study_id>
    <nct_id>NCT00038948</nct_id>
  </id_info>
  <brief_title>Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients</brief_title>
  <official_title>A Randomized, Open-label, Comparative Evaluation of Conversion From Calcineurin Inhibitors to Sirolimus Versus Continued Use of Calcineurin Inhibitors in Renal Allograft Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wyeth is now a wholly owned subsidiary of Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wyeth is now a wholly owned subsidiary of Pfizer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of conversion from calcineurin inhibitor
      to sirolimus based therapy on renal function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2002</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nankivell Glomerular Filtration Rate (GFR)</measure>
    <time_frame>52 weeks</time_frame>
    <description>Nankivell GFR: patients with baseline GFR of 20.0 to 40.0 mL/min and patients with baseline GFR of greater than 40.0 mL/min. GFR is an index of kidney function. A higher value means better kidney function.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First Occurrence of Biopsy-confirmed Acute Rejection, Graft Loss, or Death.</measure>
    <time_frame>52 and 104 weeks</time_frame>
    <description>Number of patients who experienced for the first time either biopsy-confirmed acute rejection, graft loss, or death by weeks 52 and 104. Assessed by individual endpoint and as composite endpoint (all combined).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">830</enrollment>
  <condition>Renal Transplantation</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conversion from calcineurin inhibitor immunosuppression to Sirolimus-based immunosuppression</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continued calcineurin inhibitor therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sirolimus</intervention_name>
    <description>Sirolimus, Cyclosporine A &amp; Tacrolimus are concentration controlled</description>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tacrolimus</intervention_name>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cyclosporine A</intervention_name>
    <arm_group_label>A</arm_group_label>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age greater than or equal to 13 years.

          -  Receiving CsA or tacrolimus from the time of transplantation or within 2 weeks
             thereafter

          -  Patients with a functioning allograft and a Nankivell GFR greater than or equal to 20
             mL/min, within 2 weeks before randomization

        Exclusion Criteria:

          -  Biopsy-confirmed acute rejection within 12 weeks before randomization, that was
             determined to require antirejection treatment

          -  Patients in whom kidney-pancreas or other multiple organ transplants have been
             performed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor, MD</last_name>
    <role>Study Director</role>
    <affiliation>Wyeth is now a wholly owned subsidiary of Pfizer</affiliation>
  </overall_official>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2002</study_first_submitted>
  <study_first_submitted_qc>June 6, 2002</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2002</study_first_posted>
  <results_first_submitted>May 29, 2009</results_first_submitted>
  <results_first_submitted_qc>April 22, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 14, 2010</results_first_posted>
  <last_update_submitted>April 22, 2010</last_update_submitted>
  <last_update_submitted_qc>April 22, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Wyeth (Registry Contact: Clinical Trial Registry Specialist)</name_title>
    <organization>Wyeth</organization>
  </responsible_party>
  <keyword>Renal</keyword>
  <keyword>Allograft</keyword>
  <keyword>Recipients</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
    <mesh_term>Cyclosporins</mesh_term>
    <mesh_term>Cyclosporine</mesh_term>
    <mesh_term>Sirolimus</mesh_term>
    <mesh_term>Everolimus</mesh_term>
    <mesh_term>Calcineurin Inhibitors</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients were recruited worldwide from January 2002 to September 2003.</recruitment_details>
      <pre_assignment_details>Patients were screened for two weeks.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>SRL Conversion in Stable Renal Transplant Recipients</title>
          <description>Conversion from calcineurin inhibitor immunosuppression therapy to Sirolimus-based immunosuppression therapy.</description>
        </group>
        <group group_id="P2">
          <title>CNI Continuation in Stable Renal Transplant Recipients</title>
          <description>Continued calcineurin inhibitor immunosuppression therapy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="555"/>
                <participants group_id="P2" count="275"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="386"/>
                <participants group_id="P2" count="198"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="169"/>
                <participants group_id="P2" count="77"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="131"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Nonmedical event</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>SRL Conversion in Stable Renal Transplant Recipients</title>
          <description>Conversion from calcineurin inhibitor immunosuppression therapy to Sirolimus-based immunosuppression therapy.</description>
        </group>
        <group group_id="B2">
          <title>CNI Continuation in Stable Renal Transplant Recipients</title>
          <description>Continued calcineurin inhibitor immunosuppression therapy</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="555"/>
            <count group_id="B2" value="275"/>
            <count group_id="B3" value="830"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.00" lower_limit="13.20" upper_limit="75.10"/>
                    <measurement group_id="B2" value="43.50" lower_limit="12.80" upper_limit="74.00"/>
                    <measurement group_id="B3" value="44.50" lower_limit="12.80" upper_limit="75.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="170"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="251.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="385"/>
                    <measurement group_id="B2" value="194"/>
                    <measurement group_id="B3" value="579.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Nankivell Glomerular Filtration Rate (GFR)</title>
        <description>Nankivell GFR: patients with baseline GFR of 20.0 to 40.0 mL/min and patients with baseline GFR of greater than 40.0 mL/min. GFR is an index of kidney function. A higher value means better kidney function.</description>
        <time_frame>52 weeks</time_frame>
        <population>Patients were stratified by GFR at baseline. GFR 20-40 mL/min and GFR &gt;40 mL/min.</population>
        <group_list>
          <group group_id="O1">
            <title>SRL Conversion Strata 20.0-40.0 mL/Min</title>
            <description>Conversion from calcineurin inhibitor immunosuppression therapy to Sirolimus-based immunosuppression therapy in stable renal transplant recipients</description>
          </group>
          <group group_id="O2">
            <title>CNI Continuation Strata 20.0-40.0 mL/Min</title>
            <description>Continued calcineurin inhibitor immunosuppression therapy in renal transplant recipients.</description>
          </group>
          <group group_id="O3">
            <title>SRL Conversion Strata &gt;40.0 mL/Min</title>
            <description>Conversion from calcineurin inhibitor immunosuppression therapy to Sirolimus-based immunosuppression therapy in renal transplant recipients.</description>
          </group>
          <group group_id="O4">
            <title>CNI Continuation Strata &gt;40.0 mL/Min</title>
            <description>Continued calcineurin inhibitor immunosuppression therapy in renal transplant recipients.</description>
          </group>
        </group_list>
        <measure>
          <title>Nankivell Glomerular Filtration Rate (GFR)</title>
          <description>Nankivell GFR: patients with baseline GFR of 20.0 to 40.0 mL/min and patients with baseline GFR of greater than 40.0 mL/min. GFR is an index of kidney function. A higher value means better kidney function.</description>
          <population>Patients were stratified by GFR at baseline. GFR 20-40 mL/min and GFR &gt;40 mL/min.</population>
          <units>mL/min</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="496"/>
                <count group_id="O4" value="245"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.56" spread="2.42"/>
                    <measurement group_id="O2" value="27.24" spread="3.71"/>
                    <measurement group_id="O3" value="59.04" spread="0.89"/>
                    <measurement group_id="O4" value="57.73" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Baseline GFR of 20.0 to 40.0 mL/min</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.575</p_value>
            <p_value_desc>Analysis of covariance p-value</p_value_desc>
            <method>ANCOVA</method>
            <param_type>Weighted difference</param_type>
            <param_value>-2.68</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-12.27</ci_lower_limit>
            <ci_upper_limit>6.91</ci_upper_limit>
            <estimate_desc>Data was adjusted for baseline and center.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Baseline GFR of &gt;40.0 mL/min</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.278</p_value>
            <p_value_desc>Analysis of covariance p-value</p_value_desc>
            <method>ANCOVA</method>
            <param_type>Weighted difference</param_type>
            <param_value>1.31</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-1.06</ci_lower_limit>
            <ci_upper_limit>3.69</ci_upper_limit>
            <estimate_desc>Data was adjusted for baseline and center.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>First Occurrence of Biopsy-confirmed Acute Rejection, Graft Loss, or Death.</title>
        <description>Number of patients who experienced for the first time either biopsy-confirmed acute rejection, graft loss, or death by weeks 52 and 104. Assessed by individual endpoint and as composite endpoint (all combined).</description>
        <time_frame>52 and 104 weeks</time_frame>
        <population>Patients were stratified by GFR at baseline. GFR 20-40 mL/min and GFR &gt;40 mL/min.</population>
        <group_list>
          <group group_id="O1">
            <title>SRL Conversion Strata 20.0-40.0 mL/Min</title>
            <description>Conversion from calcineurin inhibitor immunosuppression to Sirolimus-based immunosuppression</description>
          </group>
          <group group_id="O2">
            <title>CNI Continuation Strata 20.0-40.0 mL/Min</title>
            <description>Continued calcineurin inhibitor therapy</description>
          </group>
          <group group_id="O3">
            <title>SRL Conversion Strata &gt;40.0 mL/Min</title>
            <description>Conversion from calcineurin inhibitor immunosuppression to Sirolimus-based immunosuppression</description>
          </group>
          <group group_id="O4">
            <title>CNI Continuation Strata &gt;40.0 mL/Min</title>
            <description>Continued calcineurin inhibitor therapy</description>
          </group>
        </group_list>
        <measure>
          <title>First Occurrence of Biopsy-confirmed Acute Rejection, Graft Loss, or Death.</title>
          <description>Number of patients who experienced for the first time either biopsy-confirmed acute rejection, graft loss, or death by weeks 52 and 104. Assessed by individual endpoint and as composite endpoint (all combined).</description>
          <population>Patients were stratified by GFR at baseline. GFR 20-40 mL/min and GFR &gt;40 mL/min.</population>
          <units>patients</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="29"/>
                <count group_id="O3" value="497"/>
                <count group_id="O4" value="246"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>52 weeks - Acute rejection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>52 weeks - Graft loss</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>52 weeks - Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>52 weeks - Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="5"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>104 weeks - Acute rejection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="27"/>
                    <measurement group_id="O4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>104 weeks - Graft loss</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>104 weeks - Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>104 weeks - Missing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>52 weeks statistical analysis across strata</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.135</p_value>
            <p_value_desc>Tests the equality of rates between treatments across strata at 52 weeks.</p_value_desc>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>104 weeks statistical analysis across strata</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.559</p_value>
            <p_value_desc>Tests the equality of rates between treatments across strata at 104 weeks.</p_value_desc>
            <method>Cochran-Mantel-Haenszel</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>SRL Conversion in Stable Renal Transplant Recipients</title>
          <description>Conversion from calcineurin inhibitor immunosuppression therapy to Sirolimus-based immunosuppression therapy.</description>
        </group>
        <group group_id="E2">
          <title>CNI Continuation in Stable Renal Transplant Recipients</title>
          <description>Continued calcineurin inhibitor immunosuppression therapy</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="81" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hemolytic anemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>International normalized ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Iron deficiency anemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Luekocytosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Luekopenia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Lymphoma like reaction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Thrombotic thrombocytopenic purpura</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cardiovascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Congestive heart failure</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Coronary artery disorder</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cyanosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Heart arrest</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Heart failure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Infarct</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Myocardial infarct</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pulmonary embolus</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Valvular heart disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract specified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Parosmia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Aphthous stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Bloody diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Enterocolitits</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Esophageal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Esophagitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder general</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hematemesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Intestinal nercosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Intestinal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Melena</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Mouth ulcerations</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Nausea and vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Oral moniliasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Rectal disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Rectal hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Ulcerative colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Ulcerative proctitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Abdominal syndrome acute</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Accidental injury</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Allergic reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Chills and fever</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Drug level increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Face edema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Flu syndrome</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Generalized edema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Granuloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Lab test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Lymphocele</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Moniliasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Transplant rejection</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Other etiology unknown</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hepatosplenomegaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Liver damage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Liver function tests abnormal</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Liver tenderness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pancreas disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Local reaction to procedure</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Parathyroid disorder</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Blood uria nitrogren increased</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Amyloidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Calcium disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Edema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Electrolyte abnormality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Healing abnormal</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypercholesteremia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hyperlipemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hyponatremia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Peripheral edema</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Respiratory acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Arthrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Bone necrosis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Joint disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Myasthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Necrotising faciitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Carcinoma of the mouth</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gastrointestinal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Aplastic anemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Chronic leukemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Carcinoma of the lung</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Skin carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Skin granuloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Skin melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Breast carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cervix carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Endometrial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Prostatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Central nervous system anomaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Confusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hostility</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Nerve root compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Vocal chord paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney failure</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Albuminuria</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Glomerulitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hydroureter</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Kidney calculus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Kidney failure</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Kidney function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Kidney tubular disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Kidney tubular necrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Nephritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Nephrosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Nephrosis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Polycystic kidney</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Scrotal edema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Toxic nephropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Uremia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Urinary frequency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Urinary tract disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast enlargement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Dysmenorrhea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Unintended pregnancy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Apnea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Aspiration pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Chronic obstructive airway disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cough increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Interstitial pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Lung edema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Plural effusion</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pluritic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="57" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Respiratory disorder general</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Upper respiratory infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Exfoliative dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Fungal dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Maculopapular rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Skin benign neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Skin disorder general</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Sweating</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Arterial anomaly</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cerebral ischemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Embolus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypervolemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypovolemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Peripherial gangrene</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Peripherial vascual disorder</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Subarachnoid hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="545" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="264" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" subjects_affected="219" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="61" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Iron deficiency anemia</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="75" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="79" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="127" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Aphthous stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="234" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="75" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gum hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Liver function tests abnormal</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="69" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="59" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="68" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="87" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Accidental injury</sub_title>
                <counts group_id="E1" subjects_affected="98" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="39" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="75" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Face edema</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" subjects_affected="125" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Flu syndrome</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="111" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Lab test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="82" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Transplant rejection</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Flu Syndrome</sub_title>
                <counts group_id="E1" subjects_affected="62" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="177" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="71" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Local reaction to procedure</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Acidosis</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>BUN increased</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="113" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Edema</sub_title>
                <counts group_id="E1" subjects_affected="62" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypercalcemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypercholesteremia</sub_title>
                <counts group_id="E1" subjects_affected="245" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="44" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" subjects_affected="76" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hyperlipemia</sub_title>
                <counts group_id="E1" subjects_affected="317" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="83" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hyperuricemia</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hypokalemia</sub_title>
                <counts group_id="E1" subjects_affected="57" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Lactic dehydrogenase increased</sub_title>
                <counts group_id="E1" subjects_affected="70" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Peripheral edema</sub_title>
                <counts group_id="E1" subjects_affected="190" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>SGOT increased</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>SGPT increased</sub_title>
                <counts group_id="E1" subjects_affected="47" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Weight loss</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="91" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="55" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="37" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Albuminuria</sub_title>
                <counts group_id="E1" subjects_affected="166" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Amenorrhea</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="168"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="81"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <counts group_id="E1" subjects_affected="33" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Impotence</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="383"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="192"/>
              </event>
              <event>
                <sub_title>Kidney function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="73" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="168"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="81"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="168"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="81"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="127" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="58" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="168"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="81"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough increased</sub_title>
                <counts group_id="E1" subjects_affected="100" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="52" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="51" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="75" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="88" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Infection</sub_title>
                <counts group_id="E1" subjects_affected="105" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="93" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="73" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Skin disorder</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Fungal Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="48" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Herpes Simplex</sub_title>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Herpes Zoster</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="273"/>
              </event>
              <event>
                <sub_title>Skin Carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="551"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="273"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PIs agreed to allow the sponsor 60 days to review and require changes to presentations or publications but only to protect confidential information and intellectual property, and for the sponsor to file a patent application, as applicable. The PIs also agreed for data to be presented first as a joint, multi-center publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>U. S. Contact Center</name_or_title>
      <organization>Wyeth</organization>
      <email>clintrialresults@wyeth.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

